SE8101205L - Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on - Google Patents

Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Info

Publication number
SE8101205L
SE8101205L SE8101205A SE8101205A SE8101205L SE 8101205 L SE8101205 L SE 8101205L SE 8101205 A SE8101205 A SE 8101205A SE 8101205 A SE8101205 A SE 8101205A SE 8101205 L SE8101205 L SE 8101205L
Authority
SE
Sweden
Prior art keywords
carbamyl
cyano
bipyridine
procedures
preparation
Prior art date
Application number
SE8101205A
Other languages
English (en)
Other versions
SE437514B (sv
Inventor
K O Gelotte
Jr C J Opalka
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE8101205L publication Critical patent/SE8101205L/sv
Publication of SE437514B publication Critical patent/SE437514B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8101205A 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten SE437514B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (2)

Publication Number Publication Date
SE8101205L true SE8101205L (sv) 1981-08-27
SE437514B SE437514B (sv) 1985-03-04

Family

ID=22416880

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8101205A SE437514B (sv) 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Country Status (28)

Country Link
US (1) US4264609A (sv)
JP (1) JPS56128758A (sv)
KR (2) KR840002067B1 (sv)
AR (1) AR230630A1 (sv)
AT (2) AT380237B (sv)
AU (1) AU541644B2 (sv)
BE (1) BE887663A (sv)
CA (1) CA1128523A (sv)
CH (1) CH647509A5 (sv)
DE (1) DE3107306A1 (sv)
DK (1) DK171253B1 (sv)
ES (1) ES499776A1 (sv)
FI (1) FI76787C (sv)
FR (1) FR2476646A1 (sv)
GB (1) GB2070600B (sv)
HK (1) HK71789A (sv)
IE (1) IE51696B1 (sv)
IL (1) IL62161A (sv)
IT (1) IT1210992B (sv)
LU (1) LU83169A1 (sv)
MX (1) MX6908E (sv)
NL (1) NL192109C (sv)
NO (1) NO156689C (sv)
NZ (1) NZ196282A (sv)
PH (2) PH19904A (sv)
PT (1) PT72573B (sv)
SE (2) SE437514B (sv)
ZA (1) ZA811124B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685840D1 (de) 1985-04-30 1992-08-06 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
FI76787B (fi) 1988-08-31
FI76787C (sv) 1988-12-12
KR840002067B1 (ko) 1984-11-09
NL8100922A (nl) 1981-09-16
CH647509A5 (fr) 1985-01-31
IT1210992B (it) 1989-09-29
GB2070600B (en) 1984-07-11
BE887663A (fr) 1981-08-25
ATA88581A (de) 1985-09-15
CA1128523A (en) 1982-07-27
AU541644B2 (en) 1985-01-17
KR840002066B1 (ko) 1984-11-09
IL62161A0 (en) 1981-03-31
NO156689C (no) 1987-11-04
GB2070600A (en) 1981-09-09
DE3107306C2 (sv) 1990-11-29
IE810397L (en) 1981-08-26
NO156689B (no) 1987-07-27
ATA305683A (de) 1985-09-15
ES499776A1 (es) 1984-06-16
SE8402727L (sv) 1984-05-21
SE8402727D0 (sv) 1984-05-21
PH19904A (en) 1986-08-13
NL192109C (nl) 1997-02-04
JPS56128758A (en) 1981-10-08
NO810639L (no) 1981-08-27
ZA811124B (en) 1982-03-31
MX6908E (es) 1986-11-07
PT72573B (en) 1982-02-12
AT380237B (de) 1986-04-25
PH17145A (en) 1984-06-04
DK171253B1 (da) 1996-08-12
IE51696B1 (en) 1987-02-18
HK71789A (en) 1989-09-14
DE3107306A1 (de) 1981-12-17
SE452764B (sv) 1987-12-14
FR2476646A1 (fr) 1981-08-28
AT380236B (de) 1986-04-25
AR230630A1 (es) 1984-05-31
FR2476646B1 (sv) 1984-08-17
AU6748781A (en) 1981-09-03
LU83169A1 (fr) 1981-09-11
IL62161A (en) 1984-06-29
NZ196282A (en) 1983-12-16
NL192109B (nl) 1996-10-01
PT72573A (pt) 1981-03-01
FI810582L (fi) 1981-08-27
SE437514B (sv) 1985-03-04
KR830005143A (ko) 1983-08-03
JPH0141626B2 (sv) 1989-09-06
IT8119952A0 (it) 1981-02-24
US4264609A (en) 1981-04-28
DK83981A (da) 1981-08-27

Similar Documents

Publication Publication Date Title
ES2490191T3 (es) Derivados de 2-amino-nicotinamida y su uso como inhibidores de tirosina quinasa del receptor de VEGF
ES2283543T3 (es) Inhibicion de raf kinasa usando quinolil-, isoquinolil- o piridil ureas.
ES2342240T3 (es) Derivados de isoquinolina con actividad que inhibe la angiogenia.
ES2324768T3 (es) 2,6-diamino-3,5-diciano-4-arilpiridinas sustituidas y su uso como ligandos selectivos de receptores de adenosina.
ES2877678T3 (es) Método de preparación para un compuesto de pirrolopirimidina quiral
JP2021515036A5 (sv)
ES2343316T3 (es) Derivados de piridina inhibidores de la cox-2.
SE8102022L (sv) Intermediat i form av 2(ih)-pyridinoner samt forfarande for framstellning derav
GB1088531A (en) Substituted benzamides
EP3908579B1 (en) Dihydroorotate dehydrogenase inhibitors
ES2325461T3 (es) Inhibidores de pirrolotriazina cinasa.
JP7219902B2 (ja) ブルトン型チロシンキナーゼ阻害剤
JP2008517956A (ja) 二重の抗血小板性／抗凝固性ピリドキシン類似体
ES2202573T3 (es) Derivados de quinolina y de bencimidazol como antagonistas de bradiquinina.
US20170298070A1 (en) Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines
ES8507112A1 (es) Un procedimiento para la prpeparacion de compuestos de 1,4-dihidropiridina.
US4060601A (en) Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
US20190144485A1 (en) Process for Making Chloro-substituted Nucleoside Phosphoramidate Compounds
DK461881A (da) Fremgangsmaade til fremstilling af 2-phenylalkylpyrrolidin- eller- piperidin-forbindelser eller syreadditionssalte deraf
CN104804001B (zh) 4‑取代吡咯并[2,3‑d]嘧啶化合物及其用途
NO832784L (no) 5-(lavere-alkyl)-1,6-nafthyridin-2(1h)-on-forbindelser og fremgangsmaate for deres fremstilling
SE8402727L (sv) Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on
EP0003277B1 (en) Heterocycle substituted (3-loweralkylamino-2-ro-propoxy)pyridines, process for preparing the same,and pharmaceutical composition containing the same
JP2021530455A (ja) 三環式化合物
JPH11505820A5 (sv)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8101205-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8101205-6

Format of ref document f/p: F